In prostate cancer, glioblastoma, and neuroblastoma, cancer metastasis is reduced by PDZ1i, which is caused by inhibition of insulin-like growth factor-1 (IGF-1), FAK, and integrin signaling, respectively [29,30,31]. Here, IGF1 is linked to glioblastoma.